Patent details
300355
Product Name:
Varenicline, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout, in het bijzonder tartraatzout
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300355
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1044189
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
300355
Procedural language:
Dutch
First Applicant Residence Country:
Marketing Authorization
Marketing Authorization Number:
EU/1/06/360/001-010
Marketing Authorization Type:
EEA
Marketing Authorization Date:
28/09/2006
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
05/06/2008
First Marketing Authorization date:
28/09/2006
Grant date:
25/08/2008
Activation date:
13/11/2018
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
05/06/2008
SPC/SPC Extension Expiration Date:
27/09/2021
Lapsed By Expiration Date:
28/09/2021
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
05/06/2008
Name:
Pfizer Products Inc.
Address:
Eastern Point Road, 06340-5146, Groton, Connecticut, United States of America (US)
Agent
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
05/06/2008
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
39/21
Publication date:
29/09/2021
Description:
Lapse or annulment
2
Bulletin Heading:
SPC
Journal edition number:
47/18
Publication date:
14/11/2018
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
Bulletin Heading:
SPC
Journal edition number:
2008/11
Publication date:
03/11/2008
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
Bulletin Heading:
SPC
Journal edition number:
2008/08
Publication date:
01/08/2008
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Annual Fee
Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
18/09/2020
Last Annual Fee Paid Number:
23
Last Annual Fee Paid Amount:
2000 Euro
Payer:
Master Data Center
Filing date
Document type
Document Description
Number of pages
File Type
19/04/2016
Outgoing Correspondence
Decision grant
2
PDF
/5/5/3/0/0/0400300355/docs/300355_10_outgoingcorrespondence20210215042907327.pdf
05/01/2016
SPC Documents
Certificate SPC
1
PDF
/5/5/3/0/0/0400300355/docs/300355_9_supplprotectioncertificate20210215042727575.pdf
12/11/2015
Incoming Correspondence Paper
Accompanying letter incoming document
2
PDF
/5/5/3/0/0/0400300355/docs/300355_0_incomingcorrespondencepaper20151209112525970.pdf
12/11/2015
SPC Documents
Annex SPC
1
PDF
/5/5/3/0/0/0400300355/docs/300355_2_supplprotectioncertificate20210215042554236.pdf
25/08/2008
Outgoing Correspondence
Outgoing Letter
1
PDF
/5/5/3/0/0/0400300355/docs/300355_1_outgoingcorrespondence20080825.pdf
25/08/2008
SPC Documents
Certificate SPC
1
PDF
/5/5/3/0/0/0400300355/docs/300355_4_supplprotectioncertificate20210215042302513.pdf
06/06/2008
Outgoing Correspondence
Outgoing Letter
1
PDF
/5/5/3/0/0/0400300355/docs/300355_6_outgoingcorrespondence20080606.pdf
05/06/2008
SPC Documents
Annex SPC
36
PDF
/5/5/3/0/0/0400300355/docs/300355_3_supplprotectioncertificate20210215042106256.pdf
05/06/2008
SPC Documents
Annex SPC
2
PDF
/5/5/3/0/0/0400300355/docs/300355_5_supplprotectioncertificate20210215042106192.pdf
05/06/2008
Application Form
First filed application form
2
PDF
/5/5/3/0/0/0400300355/docs/300355_7_applicationform20080605.pdf
05/06/2008
SPC Documents
Summary of the characteristics of the product
21
PDF
/5/5/3/0/0/0400300355/docs/300355_8_supplprotectioncertificate20210215042106102.pdf